$0.5850
-0.0438-6.97%
Last update: Oct 23, 6:05 PM
Bluejay Diagnostics Inc (BJDX) Stock Price, Quote, News & History
BJDXNASDAQ
Bluejay Diagnostics released baseline data from its SYMON-II study, evaluating the IL-6 biomarker for mortality risk in sepsis patients.
You can purchase shares of Bluejay Diagnostics (NASDAQ:BJDX) through any online brokerage.
Other companies in Bluejay Diagnostics’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Medtronic PLC (NYSE:MDT), Stryker Corp (NYSE:SYK) and Boston Scientific Corp (NYSE:BSX).
There is no analysis for Bluejay Diagnostics to provide a consensus price target.
The stock price for Bluejay Diagnostics (NASDAQ: BJDX) is $0.589 last updated October 23, 2026 at 6:05 PM EDT.
There are no upcoming dividends for Bluejay Diagnostics.
Bluejay Diagnostics does not have any upcoming earnings scheduled.
There is no upcoming split for Bluejay Diagnostics.
Bluejay Diagnostics is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first...
